Acotec Scientific Holdings Limited

As of December 31, 2025, Acotec Scientific Holdings Limited carries a market capitalization of 4.23B, placing it among publicly traded companies globally. Its enterprise value stands at 3.45B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Acotec Scientific Holdings Limited's next confirmed earnings release is scheduled for March 29, 2027.

As of December 31, 2025, Acotec Scientific Holdings Limited has 313.39M shares outstanding.

These figures are as of December 31, 2025.

As of December 31, 2025, Acotec Scientific Holdings Limited maintains a current ratio of 5.73, meaning it holds 5.7x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended December 31, 2025.

As of the close on October 22, 2026, Acotec Scientific Holdings Limited's stock has declined approximately 55.53% over the past 52 weeks. The 50-day moving average sits at 6.17, while the 200-day moving average is 9.62.

As of December 31, 2025, Acotec Scientific Holdings Limited holds 1.05B in cash and equivalents against 271.97M in total debt, resulting in a net debt position of -368.99M. Total book value stands at 1.64B, with working capital of 1.23B providing operational flexibility.